Amphastar Pharmaceuticals, Inc. AMPH

26.13 (0.14) (0.53%) as of 25 Sep
Market cap
$1.1B
P/E
15.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
77.08 249.61 0.00 18.55 502.75 17.92 15.08 21.93 11.29 12.75
P/S ratio
3.29 3.68 3.13 2.81 2.70 2.54 2.74 4.67 2.46 1.74
P/FCF ratio
48.87 144.66 0.00 16,183.62 40.67 15.81 20.93 20.71 10.44 10.53
P/Operating CF
59.93 90.51 97.01 160.35 56.00 27.51 89.92 125.98 61.95 38.09
P/B ratio
2.55 2.65 2.53 2.12 2.11 2.50 2.59 4.70 2.46 1.59
EV/Sales
3.15 3.58 2.99 2.68 2.52 2.40 2.54 5.18 2.97 2.19
EV/EBITDA
26.71 59.05 111.51 47.81 27.18 11.25 9.54 13.54 8.23 7.87
EV/FCF
46.74 140.53 (221.59) 15,426.84 37.95 14.93 19.37 22.99 12.64 13.27
Current Ratio
3.04 2.79 2.06 2.84 2.49 3.06 3.99 2.17 3.07 4.02
Net Debt/EBITDA
(1.22) (1.73) (5.46) (2.35) (1.95) (0.67) (0.77) 1.34 1.43 1.62
Debt/Equity
0.11 0.14 0.14 0.11 0.10 0.17 0.14 0.92 0.82 0.77
ROE
3.14% 1.10% (1.64%) 12.36% 0.32% 13.89% 18.76% 23.55% 23.26% 12.90%
ROA
2.40% 0.83% (1.19%) 8.89% 0.23% 9.54% 12.93% 12.20% 10.32% 6.12%
ROIC
3.28% (0.26%) (1.68%) (0.01%) 1.78% 11.39% 15.76% 12.69% 11.57% 7.88%
Return on Tangible Assets
3.55% 1.21% (1.77%) 12.26% 0.33% 13.55% 17.52% 25.15% 24.26% 12.44%
Average Days of Receivables
38.33 63.88 64.67 51.73 69.27 65.81 65.08 65.40 68.83 81.49
Earnings Yield
1.30% 0.40% (0.65%) 5.39% 0.20% 5.58% 6.63% 4.56% 8.86% 7.84%
Free Cash Flow Yield
2.05% 0.69% (0.43%) 0.01% 2.46% 6.33% 4.78% 4.83% 9.58% 9.49%
Free Cash Flow per Share
0.38 0.13 (0.09) 0.00 0.50 1.48 1.35 3.01 3.56 2.55
Book value per Share
7.26 7.24 7.85 9.10 9.54 9.33 10.89 13.25 15.12 16.88
Free Cash Flow
17.18 6.11 (3.97) 0.21 23.41 70.54 65.57 145.34 172.35 118.98
EV/EBIT
52.22 0.00 0.00 0.00 80.58 15.03 11.78 16.94 10.59 11.23
Other line items

Show all line items

Columns are period end dates